Metaplastic breast cancer: A single-centre retrospective experience.
Research clarifies rare metaplastic breast cancer biology, potentially improving future treatment strategies.
This PubMed record reports metaplastic Breast Cancer (MpBC) is a rare disease entity accounting for less than 1% of all breast cancers. The study was classified as randomized controlled trial and is relevant to treatment innovation.
What the study was
- Study design
- Randomized controlled trial
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
Why it surfaced
Conservative triage based on the PubMed abstract, randomized controlled trial, clinical relevance, and unmet-need signals.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.